Company / Current Liabilities per Share
CUMBERLAND PHARMACEUTICALS INC Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.63
FY2025
5-year range
$1.29 / $2.63
FY2021-FY2025
Trend
+17.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has increased for 4 consecutive years, from $1.29 in FY2021 to $2.63 in FY2025.
Based on SEC 10-K filings.
2.63 in FY2025 with a 5-year CAGR of +9.4%.
Increased from $1.95 to $2.63 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +10.8%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- CUMBERLAND PHARMACEUTICALS INC's current liabilities per share has grown for 4 consecutive years.
- In FY2025, current liabilities per share increased 17.6% year-over-year.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.63 | +17.6% |
| FY2024 | $2.24 | +15.0% |
| FY2023 | $1.95 | +0.5% |
| FY2022 | $1.94 | +50.7% |
| FY2021 | $1.29 | -23.5% |
| FY2020 | $1.68 | +7.8% |
| FY2019 | $1.56 | -9.8% |
| FY2018 | $1.73 | +57.1% |
| FY2017 | $1.10 | +21.9% |
| FY2016 | $0.90 | +24.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026